Mao‐Wang Ho

2.3k total citations
95 papers, 1.4k citations indexed

About

Mao‐Wang Ho is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Mao‐Wang Ho has authored 95 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Infectious Diseases, 41 papers in Epidemiology and 18 papers in Clinical Biochemistry. Recurrent topics in Mao‐Wang Ho's work include Antifungal resistance and susceptibility (19 papers), Bacterial Identification and Susceptibility Testing (17 papers) and Antibiotic Resistance in Bacteria (16 papers). Mao‐Wang Ho is often cited by papers focused on Antifungal resistance and susceptibility (19 papers), Bacterial Identification and Susceptibility Testing (17 papers) and Antibiotic Resistance in Bacteria (16 papers). Mao‐Wang Ho collaborates with scholars based in Taiwan, United States and China. Mao‐Wang Ho's co-authors include Po‐Chang Lin, Cheng‐Mao Ho, Jen-Hsien Wang, Chi‐Hua Yen, Chia-Hui Chou, Wei‐Chih Liao, Ni Tien, Chin‐Ming Chen, Yuag-Meng Liu and Min‐Chi Lu and has published in prestigious journals such as Nature Medicine, PLoS ONE and Journal of Agricultural and Food Chemistry.

In The Last Decade

Mao‐Wang Ho

87 papers receiving 1.4k citations

Peers

Mao‐Wang Ho
In‐Gyu Bae South Korea
C. Ruef Switzerland
Sheldon Campbell United States
Christian Chuard Switzerland
In‐Gyu Bae South Korea
Mao‐Wang Ho
Citations per year, relative to Mao‐Wang Ho Mao‐Wang Ho (= 1×) peers In‐Gyu Bae

Countries citing papers authored by Mao‐Wang Ho

Since Specialization
Citations

This map shows the geographic impact of Mao‐Wang Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mao‐Wang Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mao‐Wang Ho more than expected).

Fields of papers citing papers by Mao‐Wang Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mao‐Wang Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mao‐Wang Ho. The network helps show where Mao‐Wang Ho may publish in the future.

Co-authorship network of co-authors of Mao‐Wang Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Mao‐Wang Ho. A scholar is included among the top collaborators of Mao‐Wang Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mao‐Wang Ho. Mao‐Wang Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Cheng‐Han, Hsiu-Hsien Lin, Wei Hsu, et al.. (2025). Evaluation of the Roche cobas MTB and MTB-RIF/INH for detecting Mycobacterium tuberculosis complex and resistance to isoniazid and rifampicin: A prospective, multicenter diagnostic accuracy study. International Journal of Antimicrobial Agents. 66(6). 107605–107605.
2.
Lu, Po‐Liang, Shang‐Yi Lin, Po‐Ren Hsueh, et al.. (2025). Longitudinal molecular epidemiology of ceftriaxone-resistant enterobacterales in intra-abdominal and urinary tract infections: A decade-long SMART surveillance study in Taiwan (2009–2019). Journal of Microbiology Immunology and Infection. 59(2). 221–229.
3.
Ho, Mao‐Wang, et al.. (2024). Disseminated Cryptococcal Gattii infection in a patient with anti-granulocyte-macrophage colony-stimulating-factor autoantibody: a case report. BMC Infectious Diseases. 24(1). 1413–1413. 1 indexed citations
4.
Chang, Yu‐Fang, Yiping Huang, Mao‐Wang Ho, et al.. (2024). RAGE participates in the intracellular transport of Campylobacter jejuni cytolethal distending toxin. Journal of Microbiology Immunology and Infection. 57(5). 709–719. 2 indexed citations
7.
Yu, Jiaxin, Yu-Tzu Lin, Wei-Cheng Chen, et al.. (2023). Prediction of methicillin-resistant Staphylococcus aureus and carbapenem-resistant Klebsiella pneumoniae from flagged blood cultures by combining rapid Sepsityper MALDI-TOF mass spectrometry with machine learning. International Journal of Antimicrobial Agents. 62(6). 106994–106994. 16 indexed citations
9.
Ho, Mao‐Wang, Ni Tien, Te‐Mao Li, et al.. (2023). Association of combination antiretroviral therapy with risk of neurological diseases in patients with HIV/AIDS in Taiwan: a nested case-control study. Frontiers in Pharmacology. 14. 1110605–1110605.
10.
Ko, Wen‐Chien, et al.. (2023). Geographic patterns of antimicrobial susceptibilities for Bacteroides spp. worldwide: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2007–2020. International Journal of Antimicrobial Agents. 62(1). 106822–106822. 5 indexed citations
11.
Lin, Chun‐Ju, Ning‐Yi Hsia, De‐Kuang Hwang, et al.. (2023). Diagnosis and Treatment of Tubercular Uveitis in Taiwan - Consensus of Expert Panels. Ocular Immunology and Inflammation. 32(7). 1420–1426. 1 indexed citations
12.
Chen, Tzu‐Ting, et al.. (2022). High rate of invasive fungal infections during early cycles of azacitidine for patients with acute myeloid leukemia. Frontiers in Cellular and Infection Microbiology. 12. 1012334–1012334. 9 indexed citations
13.
Ho, Mao‐Wang, Te‐Mao Li, Ju‐Pi Li, et al.. (2021). Chinese Herbal Medicine Usage Reduces Overall Mortality in HIV-Infected Patients With Osteoporosis or Fractures. Frontiers in Pharmacology. 12. 593434–593434. 3 indexed citations
14.
Ho, Mao‐Wang, Wei‐Chih Liao, Yuan Chen, et al.. (2020). Long-Term Surveillance of Antibiotic Prescriptions and the Prevalence of Antimicrobial Resistance in Non-Fermenting Gram-Negative Bacilli. Microorganisms. 8(3). 397–397. 11 indexed citations
15.
Chiang, Hsiu‐Yin, et al.. (2019). Risk prediction for 30-day mortality among patients with Clostridium difficile infections: a retrospective cohort study. Antimicrobial Resistance and Infection Control. 8(1). 175–175. 15 indexed citations
16.
Lin, Po‐Chang, et al.. (2014). Management and outcome of adults with skin and soft tissue infection caused by methicillin-resistant Staphylococcus aureus in a tertiary hospital in central Taiwan. Journal of Microbiology Immunology and Infection. 48(5). 497–503. 4 indexed citations
17.
Ho, Mao‐Wang, Chia‐Der Lin, Cheng‐Wen Lin, et al.. (2013). Repeated Colonization by Multi-Drug-Resistant Acinetobacter calcoaceticus–A. baumannii Complex and Changes in Antimicrobial Susceptibilities in Surgical Intensive Care Units. Surgical Infections. 14(1). 43–48. 6 indexed citations
18.
Liu, Yuag-Meng, Po‐Chang Lin, Cheng‐Mao Ho, et al.. (2012). Report of a 63-case series of Candida empyema thoracis: 9-year experience of two medical centers in central Taiwan. Journal of Microbiology Immunology and Infection. 47(1). 36–41. 18 indexed citations
19.
Lin, Po‐Chang, et al.. (2008). Demographic and clinical features of leptospirosis: three-year experience in central Taiwan.. PubMed. 41(2). 145–50. 14 indexed citations
20.
Lin, Chia‐Der, et al.. (2002). Adenoid Bacteriology in Otitis Media Children With Effusion. 7(4). 199–205. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026